[{"arm_notes": "", "treatment_id": null, "treatment_name": "COVID-19 patients are randomly assigned to the group which adds Favipiravir and Nafamostat Mesilate to standard treatment or the group which add Favipiravir to standard treatment", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 504, "treatment_name": "Favipiravir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1514, "treatment_name": "Favipiravir+nafamostat mesilate", "treatment_type": "Antivirals+coagulation modifiers", "pharmacological_treatment": "Pharmacological treatment"}]